Revolution Medicines to Provide R&D Pipeline Update, Including Progress of RAS(ON) Inhibitor Programs, During Presentation at 39th Annual J.P. Morgan Healthcare Conference

Rhythm Pharmaceuticals Announces Sale of Priority Review Voucher for $100M

Pliant Therapeutics Announces Appointment of Gregory P. Cosgrove, M.D., FCCP, as Vice President of Clinical Development, IPF

Voyager Therapeutics Provides Update On NBIb-1817 (VY-AADC) Gene Therapy Program

CytomX Therapeutics Appoints Dr. Mani Mohindru to Board of Directors